Sponsored by:

Nuclear Medicine: Page 188

Positron appoints Conroy to COO post
By AuntMinnie.com staff writers
PET vendor Positron announced it has named Charles Conroy as chief operating officer (COO).
November 14, 2012
International Isotopes' revenue declines in Q3
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes cited an overall reduction in operating nuclear medicine clinics in the U.S. and budgetary constraints at a number of facilities as two reasons for a decrease in revenue in the third-quarter and nine-month periods.
November 14, 2012
PET volume, glycolytic activity predict NSCLC local recurrence
By Wayne Forrest
By characterizing non-small cell lung cancer (NSCLC) tumors through glycolytic activity and FDG-PET volume after stereotactic body radiation therapy, clinicians may be able to detect which tumors are likely to recur, according to a study presented at the American Society for Radiation Oncology meeting.
November 8, 2012
Slow growth expected for U.S. imaging market
By AuntMinnie.com staff writers
The U.S. diagnostic imaging system market will grow slowly to reach a total size of $4.5 billion by 2017, according to a new report from market research firm Millennium Research Group.
November 5, 2012
CMS meeting to review PET amyloid coverage
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) will convene an advisory committee meeting in January 2013 to review its policies regarding coverage of PET imaging studies of beta amyloid in the brain.
October 31, 2012
Lantheus extends molybdenum-99 supply contract
By AuntMinnie.com staff writers
Diagnostic imaging agent developer Lantheus Medical Imaging has extended its contract with NTP Radioisotopes, a subsidiary of the South African Nuclear Energy Corporation.
October 30, 2012
Navidea tries again with Lymphoseek NDA
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has resubmitted a new drug application (NDA) to the U.S. Food and Drug Administration for its Lymphoseek radiopharmaceutical.
October 30, 2012
Dilon touts low-dose breast imaging results
By AuntMinnie.com staff writers
Breast-specific gamma imaging provider Dilon Diagnostics said that new research shows its gamma camera can perform molecular breast imaging at half of the normal radiation dose by halving the amount of radiotracer, with no loss of diagnostic ability.
October 25, 2012
Naviscan signs PEM distribution deal
By AuntMinnie.com staff writers
PET developer Naviscan has entered into a sales agreement in which Ledford Medical Electronics will augment Naviscan's U.S. direct sales staff in distributing its positron emission mammography (PEM) scanner.
October 25, 2012
NaF-PET/CT detects bone mets in prostate cancer patients
By Wayne Forrest
The use of PET/CT with a sodium fluoride (NaF) radiopharmaceutical produces high sensitivity, suggesting that the modality can be beneficial in detecting bone metastases caused by prostate cancer, according to a study published in the November issue of the American Journal of Roentgenology.
October 25, 2012
2012 10 25 15 14 34 684 2012 11 Ajr Mosavi B Thumb
NCM to collaborate with Genentech
By AuntMinnie.com staff writers
PET radiopharmaceutical developer NCM USA said it has signed a technology development and supply agreement with Genentech.
October 23, 2012
Study finds PET utilization varies along racial, income lines
By Wayne Forrest
A five-year analysis of Medicare beneficiaries with cancer has found greater utilization of PET imaging among white patients with greater income levels in areas of higher Medicare spending.
October 22, 2012
Previous Page
Page 188 of 440
Next Page